2007 Rutgers Biostatistics Day

A conference to celebrate Biostatistics Research

Institute of Biostatistics
Department of Statistics & Biostatistics,
Rutgers University

Co-sponsors:
               Merck, Inc.
               Novartis Pharmaceuticals
               Pfizer, Inc.
               Sanofi-Aventis, Inc.

Time: Friday, February 16, 2007, 9:00AM
Place: Fiber Optics Auditorium, Busch Campus, Rutgers.

TALK SLIDES FOUND HERE

The Department of Statistics and Biostatistics at Rutgers University, and its Biostatistics Institute, is hosting the second Rutgers Biostatistics Day on Friday, February 16, 2007. One of the main objectives of the Biostatistics Institute is to foster collaborative research on Biopharmaceutical Statistics. The Rutgers Biostatistics Days are periodic events designed to provide opportunities for interactions between statisticians from both industry and academia. We invite you to join us on February 16, and find out more about the new initiatives of the Rutgers Biostatistics Institute.

Program

9:00AM-9:25AM: Registration.

9:25AM-9:30AM: Opening remarks.

9:30AM-10:05AM: Session I: "New Frontiers in Biopharmaceutical research"

Chair: Jose Alvir, Pfizer.

David Madigan, Rutgers University. "Lasso Regression: Some Recent Developments."

10:15AM-12:00PM: Session II: "New developments in clinical studies Part I"

Chair: Dirk Moore, UMDNJ.,

Leonard Oppenheimer, Johnson & Johnson. "Extension Studies"

Mani Lakshminarayanan Pfizer. "Handling Count Data in Clinical Trials"

Hui Quan, Sanofi-Adventis, "Analysis of a Composite Endpoint with Missing Data in Components"

12:00PM-1:30PM: Lunch Break

1:30PM-2:40PM: Session III "New developments in clinical studies Part II"

Chair: James Colaianne, Johnson & Johnson.

Jose Pinheiro, Novartis. "Evaluating Adaptive Dose-Ranging Studies and Methods: A Report from the PhRMA Working Group"

Vladimir Dragalin, Wyeth. "Adaptive model-based designs in clinical drug development"

2:55PM-4:40PM: Session IV: "Bayesian methodology application in clinical studies"

Chair: William Mietlowski. Novartis.

Inna Perevozskaya, Merck. "Bayesian Optimal Designs for Phase I Clinical Trials in Oncology"

Pablo Bonangelino, Food and Drug Administration. "Bayesian Designs for Therapeutic Medical Device Trials".

William E. Strawderman, Rutgers University. "Combining Biased and Unbiased Estimates in High Dimensions".

4:40PM-6:00PM: Reception.

The wine and cheese reception will provide a great opportunity for further interaction.

Additional Information

1. Registration. There is no registration fee. To facilitate planning for this event participants are required to register on line by Feb 10.

2. Driving directions and parking

3. Organizing committee
     Javier Cabrera (chair), Email: cabrera@stat.rutgers.edu
     John Kolassa, Email: kolassa@stat.rutgers.edu
     Regina Liu, Email: rliu@stat.rutgers.edu
     Bill Strawderman, Email: straw@stat.rutgers.edu


4. Conference coordinator.
      Marcy Collins. Email: collins@stat.rutgers.edu


Please direct all questions regarding this conference webpage to collins@stat.rutgers.edu
Last updated: February 19, 2007, 6:29 pm

© 2008 Rutgers, The State University of New Jersey. All rights reserved.